As IL-6 has a multi-factorial role in promoting cancer cell proliferation, metastasis, and cancer stem cell induction19–23, we investigated in vitro the potential efficacy of neutralizing MSL TNBC autocrine IL-6 production in combination with docetaxel treatment. Here, IL6 is linked to cancer.